D-0766-2023 Class III Terminated
FDA drug recall D-0766-2023 was initiated by Teva Pharmaceuticals USA Inc on Apr 27, 2023 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert The recall status is terminated (terminated Feb 29, 2024). Affected quantity: 438.
Recall details
- Product Type
- Drugs
- Report Date
- May 31, 2023
- Initiation Date
- Apr 27, 2023
- Termination Date
- Feb 29, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 438
Product description
Fentanyl Buccal Tablets CII, 100mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-634-28
Reason for recall
Labeling: Incorrect or Missing Package Insert
Distribution pattern
US Nationwide
Code information
Lot# 42617828, Exp 06/2023; 100020465, Exp 01/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0766-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026